Dr. Sun-Young Han
My Social Links

Dr. Sun-Young Han

Professor
College of Pharmacy, Gyeongsang National University, Republic of Korea

Highest Degree
Ph.D. in Pharmacology from University Of Colorado, USA

Share this Profile

Area of Interest:

Area of Interest
100%

Research Publications in Numbers

Books
0
Chapters
0
Articles
47
Abstracts
0

Selected Publications

  1. Jeong, P., Y. Moon, J.H. Lee, S.D. Lee and J. Park et al., 2020. Discovery of orally active indirubin-3'-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia. Eur. J. Med. Chem., Vol. 195. 10.1016/j.ejmech.2020.112205.
    CrossRef  |  Direct Link  |  
  2. Yoon, K.B., H.J. Lee, H.J. Chung, J. Lee and J.C. Jeong et al., 2019. Discovery of LDD-1075 as a potent FLT3 inhibitor. Oncol. Lett., 17: 4735-4741.
    CrossRef  |  Direct Link  |  
  3. Ndolo, K.M., S.J. An, K.R. Park, H.J. Lee, K.B. Yoon, Y.C. Kim and S.Y. Han, 2019. Discovery of an indirubin derivative as a novel c-met kinase inhibitor with in vitro anti-tumor effects. Biomol. Ther., 27: 283-289.
  4. Lee, H.J., J. Lee, P. Jeong, J. Choi and J. Baek et al., 2018. Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia. Oncotarget, 9: 924-936.
    CrossRef  |  Direct Link  |  
  5. Yoon, K.B., S.Y. Cho, S.J. An, K.R. Park and H.J. Lee et al., 2017. Characterization of the aminopyridine derivative KRC-180 as a JAK2 inhibitor. Oncol. Lett., 14: 1347-1354.
    CrossRef  |  Direct Link  |  
  6. Ndolo, K.M., K.R. Park, H.J. Lee, K.B. Yoon, Y.C. Kim and S.Y. Han, 2017. Characterization of the indirubin derivative LDD970 as a small molecule aurora kinase a inhibitor in human colorectal cancer cells. Immune Network, 17: 110-115.
    CrossRef  |  Direct Link  |  
  7. Lee, H.J., B.K. Kim, K.B. Yoon, Y.C. Kim and S.Y. Han, 2017. Novel inhibitors of lysine (K)-specific Demethylase 4A with anticancer activity. Invest. New Drugs, 35: 733-741.
    CrossRef  |  Direct Link  |  
  8. Lee, C., J. Baek and S.Y. Han, 2017. The role of kinase modulators in cellular senescence for use in cancer treatment. Molecules, Vol. 22. 10.3390/molecules22091411.
    CrossRef  |  Direct Link  |  
  9. Yoon, K.B., K.R. Park, S.Y. Kim and S.Y. Han, 2016. Induction of nuclear enlargement and senescence by sirtuin inhibitors in glioblastoma cells. Immune Network, 16: 183-188.
    CrossRef  |  Direct Link  |  
  10. Song, D.H., G.H. Ko, J.H. Lee, J.S. Lee and G.W. Lee, 2016. Myoferlin expression in non-small cell lung cancer: Prognostic role and correlation with VEGFR-2 expression. Oncol. Lett., 11: 998-1006.
    CrossRef  |  Direct Link  |  
  11. Lee, S.M., K.B. Yoon, H.J. Lee, J. Kim and Y.K. Chung et al., 2016. The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3. Bioorg. Med. Chem., 24: 5036-5046.
    CrossRef  |  Direct Link  |  
  12. Kim, D.C., K.R. Park, Y.J. Jeong, H. Yoon and M.J. Ahn et al., 2016. Resistance to the c-Met inhibitor KRC-108 induces the epithelial transition of gastric cancer cells. Oncol. Lett., 11: 991-997.
    CrossRef  |  Direct Link  |  
  13. Chung, H.J., K.R. Park, H.J. Lee, J. Lee, J.H. Kim, Y.C. Kim and S.Y. Han, 2015. Effects of KRC-108 on the aurora A activity and growth of colorectal cancer cells. Biochem. Biophys. Res. Commun., 461: 605-611.
    CrossRef  |  Direct Link  |  
  14. Choi, Y.O., H.H. Song, Y.M. Kim, N.S. Kang, S.Y. Han and Y.W. Chin, 2015. c-Met and ALK inhibitory constituents from Scutellaria baicalensis. Bull. Korean Chem. Soc., 36: 402-405.
    CrossRef  |  Direct Link  |  
  15. Chin, Y.W. and S.Y. Han, 2015. KDM4 histone demethylase inhibitors for anti-cancer agents: A patent review. Expert Opin. Ther. Pat., 25: 135-144.
    CrossRef  |  Direct Link  |